BBV April bulletin summary

The Blood Born Virus Sector Development Program newsletter contains HIV and viral hepatitis research, resources, projects, events and services in Victoria, Australia.

HIV Pre Exposure Prophylaxis now available on the PBS!

On 21 March 2018, the Federal Minister for Health announced that PrEP will be subsidised by the Australian Government through the Pharmaceutical Benefits Scheme (PBS) from 1 April 2018. This means that any doctor or general practitioner is now able to PrEP to Medicare eligible Australians. The monthly cost of PrEP will $39.50 or $6.40 for those on concession.

PrEP has the potential to significantly impact Australia’s response to the HIV epidemic. It is an important new option in the suite of HIV prevention strategies and, alongside treatment as prevention, will support Australia to meet its target of ending HIV transmission. People at high risk of HIV are eligible for PrEP. In Australia, some sexually active gay and bisexual men, transgender people and heterosexual people with an HIV positive partner who does not have an undetectable viral load are population groups that are at high risk. Research shows that the medication used for PrEP is highly effective at preventing HIV transmission among these population groups.

RACGP have prepared an article outlining what GPs need to know to prescribe PrEP in general practice

The rest of the bulletin

This issue of the BBV bulletin focuses on

It also includes information regarding research, specifically

View the rest of the current issue

Subscribe to the BBV News e-bulletin.

Find an expert

Search our experts database.